Company Filing History:
Years Active: 2024
Title: Praveen B Managutti: Innovator in Anti-Inflammatory Agents
Introduction
Praveen B Managutti is a notable inventor based in Al-Ahsa, Saudi Arabia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. His innovative work has the potential to impact the treatment of various inflammatory conditions.
Latest Patents
Praveen holds a patent for "Dimethyl 7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agents." This patent describes novel compounds that are useful for treating inflammation, pain, and swelling in patients. The patent outlines a method for synthesizing these compounds, a pharmaceutical composition that includes them along with a suitable carrier, and methods for their application in medical treatments. He has 1 patent to his name.
Career Highlights
Praveen is affiliated with King Fahd University of Petroleum and Minerals, where he contributes to research and development in the field of pharmaceuticals. His work is characterized by a commitment to innovation and the advancement of medical science.
Collaborations
Praveen has collaborated with esteemed colleagues such as Katharigatta N Venugopala and Pran Kishore Deb. These collaborations have further enriched his research and development efforts.
Conclusion
Praveen B Managutti is a distinguished inventor whose work in anti-inflammatory agents showcases his dedication to improving healthcare. His contributions are paving the way for new treatments that can alleviate suffering for many patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.